Albuminuria

Cross-source consensus on Albuminuria from 1 sources and 4 claims.

1 sources · 4 claims

Comparisons

Incident albuminuria was assessed in a separate analysis among patients with baseline urinary albumin-to-creatinine ratio below 30 mg/g creatinine. — Lobeglitazone and the risk of renal progression in Korean patients with type 2 diabetes mellitus: a retrospective cohort study
Lobeglitazone plus metformin had a lower but non-significant incident albuminuria risk compared with metformin monotherapy. — Lobeglitazone and the risk of renal progression in Korean patients with type 2 diabetes mellitus: a retrospective cohort study
Incident albuminuria risks were comparable for lobeglitazone plus metformin versus sulfonylurea plus metformin and DPP4 inhibitor plus metformin. — Lobeglitazone and the risk of renal progression in Korean patients with type 2 diabetes mellitus: a retrospective cohort study
Incident albuminuria results followed the same general pattern as the primary renal outcome. — Lobeglitazone and the risk of renal progression in Korean patients with type 2 diabetes mellitus: a retrospective cohort study